Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Notable Labs's earnings per share without non-recurring items for the
three
months ended in Jun. 2024 was $-0.56.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.98.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Notable Labs's EPS without NRI or its related term are showing as below:
NTBLQ's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.4 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Notable Labs's EPS (Diluted) for the
three
months ended in Jun. 2024 was $-0.55.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.97.
Notable Labs's EPS (Basic) for the
three
months ended in Jun. 2024 was $-0.55.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.97.
Notable Labs (OTCPK:NTBLQ) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Notable Labs EPS without NRI Related Terms
Notable Labs EPS without NRI Historical Data
* Premium members only.
The historical data trend for Notable Labs's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NTBLQ vs VRTX, REGN, ALNY: EPS without NRI Comparison
For the Biotechnology subindustry, Notable Labs's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Notable Labs PE Ratio without NRI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Notable Labs's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Notable Labs's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Notable Labs (NTBLQ) has a EPS without NRI of $-0.98 as of Jun. 2024. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Notable Labs and its competitors.
Is Notable Labs' EPS without NRI too high?
Notable Labs' current EPS without NRI is $-0.98.
How does Notable Labs' EPS without NRI compare to VRTX and REGN?
Notable Labs' EPS without NRI of $-0.98 can be compared against companies in the Biotechnology industry. The industry median EPS without NRI is 16.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.40, based on 1,168 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Notable Labs and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Notable Labs's current EPS without NRI is $-0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current EPS without NRI of $-0.98. The current EPS without NRI is $-0.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current EPS without NRI is $-0.98 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NTBLQ has been successfully added to your 
